EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Outcome of treatment with a 10‐week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014‐2023)

M M E Larsen iD, A-M Andersson, M Arendt

Journal of Small Animal Practice · 2024

DOI: 10.1111/jsap.13772 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Small Animal Practice, 2024. Verfasst von M M E Larsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Evidensia Specialist Animal Hospital in Helsingborg, Helsingborg, Sweden. Hauptthemen laut MEDLINE: Cat Diseases, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: IVC Evidensia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this retrospective clinical study was to evaluate and report response to treatment with a 10‐week maintenance‐free COP (COP‐10) protocol in a cohort of 27 cats with intermediate or large cell lymphoma. Additionally, to identify any potential prognostic factors for predicting the treatment response. Materials and Methods The medical records of cats diagnosed with intermediate or large cell lymphoma in a single institution in the period 2014 to 2023 and treated with COP‐10 as first‐line treatment were reviewed.

Results

Twenty‐seven cats were included in the study. The median age was 10 years, 67% of the cats were in stages I to II and the most common anatomical location was alimentary (37%). The overall response rate was 65%, with 38% of cats achieving complete remission and 27% partial remission. For cats achieving complete remission, the median progression‐free interval and the median lymphoma‐specific survival time were both 1,139 days. For cats in partial remission, the median progression‐free interval and the median lymphoma‐specific survival time were 53 and 210 days, respectively. Clinical stage was significantly related to treatment response and survival time. Clinical Significance Treatment with the short protocol COP‐10 resulted in remission rates and durable first remissions for cats achieving complete remission comparable to responses seen with longer‐duration chemotherapy protocols. The results from this study may impact economic and logistic decisions for owners, as well as the quality of life for patients in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesAntineoplastic Combined Chemotherapy ProtocolsCatsAnimalsMaleRetrospective StudiesFemaleTreatment OutcomeRemission InductionLymphoma

Autor:innen und Institutionen

  • Evidensia Specialist Animal Hospital in Helsingborg, Helsingborg, Sweden.
  • IVC Evidensia, The Chocolate Factory, Bristol, UK.
  • Department of Veterinary Clinical Sciences, University of Copenhagen, KU SUND, Copenhagen, Denmark.

ORCID-Profile: M M E Larsen

Förderung

  • IVC Evidensia

Zitieren

APA

Larsen, M. M. E., Andersson, A. M., & Arendt, M. (2024). Outcome of treatment with a 10‐week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014‐2023). Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13772

Vancouver

Larsen MME, Andersson AM, Arendt M. Outcome of treatment with a 10‐week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014‐2023). Journal of Small Animal Practice. 2024. doi:10.1111/jsap.13772

BibTeX
@article{Larsen2024,
  author = {Larsen, M M E and Andersson, A-M and Arendt, M},
  title = {Outcome of treatment with a 10‐week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014‐2023)},
  journal = {Journal of Small Animal Practice},
  year = {2024},
  doi = {10.1111/jsap.13772}
}
Kostenlos starten →